Real-World Experience With a Large Bore Vascular Closure Device During TAVI Procedure: Features and Predictors of Access-Site Vascular Complications

Giulia Masiero,Livio D'Angelo,Luca Nai Fovino,Tommaso Fabris,Francesco Cardaioli,Giulio Rodinò,Alice Benedetti,Mauro Boiago,Saverio Continisio,Carolina Montonati,Tommaso Sciarretta,Vittorio Zuccarelli,Andrea Scotti,Giulia Lorenzoni,Andrea Pavei,Massimo Napodano,Chiara Fraccaro,Sabino Iliceto,Alfredo Marchese,Giovanni Esposito,Giuseppe Tarantini
DOI: https://doi.org/10.3389/fcvm.2022.832242
IF: 3.6
2022-02-28
Frontiers in Cardiovascular Medicine
Abstract:Backgrounds Among vascular closure devices (VCDs), the novel collagen plug-based MANTA VCD is the first designed for large bore percutaneous access. We aimed to assess the features and predictors of access-site vascular complications in an unselected trans-femoral transcatheter aortic valve replacement (TF-TAVR) population. Methods Patients undergoing large bore arteriotomy closure with 18F MANTA VCD following TF-TAVR at a large tertiary care center from September 2019 to January 2021 were prospectively analyzed. Primary Outcome was the MANTA VCD access-site-related complications according to Valve Academic Research Consortium-3 (VARC) definitions. Its incidence and predictors were evaluated. Results Eighty-eight patients (median age 82 years, 48% male, 3.3 median Society of Thoracic Surgeons score) undergoing TF-TAVR were included, mostly (63%) treated with a self-expandable device and with outer diameter sizes varied from 18F to 24-F. MANTA VCD technical success rate was 98%, while 10 patients (11%) experienced MANTA VCD access-site vascular complications which included 8% of minor complications and only to 2% of major events resulting in VARC type ≥2 bleeding. Vessel occlusion/stenosis (60%), perforation (20%), and pseudoaneurysm/dissection/hematoma (20%) occurred, but all were managed without surgical treatment. Independent predictors of failure were age ( p = 0.04), minimum common femoral artery diameter (CFA) ( p < 0.01), sheath-to-femoral-artery ratio (SFAR) ( p < 0.01), and a lower puncture height ( p = 0.03). A CFA diameter <7.1 mm with a SFAR threshold of 1.01 were associated with VCD failure. Conclusions In a more comers TF-TAVR population, MANTA VCD was associated with reassuring rates of technical success and major access-site vascular complications. Avoiding lower vessel size and less puncture site distance to CFA bifurcation might further improve outcomes.
cardiac & cardiovascular systems
What problem does this paper attempt to address?